Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
Alfiah Amiruddin, Muhammad Nasrum Massi, Andi Asadul Islam, et al.
Annals of Medicine and Surgery (2021) Vol. 73
Open Access | Times Cited: 23

Showing 23 citing articles:

Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
Ahmed Ismail, Hesham A. El-Mahdy, Ahmed I. Abulsoud, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 1541-1565
Closed Access | Times Cited: 66
The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application
Juan P. Muñoz, Pablo Ernesto Pérez, Yasmín P. Pérez, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3072-3072
Open Access | Times Cited: 30
Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
Raj Pranap Arun, Hannah F. Cahill, Paola Marcato
Biomedicines (2022) Vol. 10, Iss. 3, pp. 651-651
Open Access | Times Cited: 22
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer
Oliver Treeck, Silke Haerteis, Olaf Ortmann
Cancers (2023) Vol. 15, Iss. 6, pp. 1632-1632
Open Access | Times Cited: 15
An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer
Monisha Prasad, D. Hamsa, Muhammad Fareed, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
miRNAs as emerging predictors of tamoxifen resistance in breast cancer
Elmira Aboutalebi Vand Beilankouhi, Reza Safaralizadeh, Babak Nejati, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
Luis Bouz Mkabaah, Matthew G. Davey, James C. Lennon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7115-7115
Open Access | Times Cited: 10
The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy
Amir Ebrahimi, Peyman Bakhshaei Shahrebabaki, Hadi Fouladi, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154702-154702
Closed Access | Times Cited: 7
Functions of Differentially Regulated miRNAs in Breast Cancer Progression: Potential Markers for Early Detection and Candidates for Therapy
Kumar Subramanian, Raghu Sinha
Biomedicines (2024) Vol. 12, Iss. 3, pp. 691-691
Open Access | Times Cited: 2
Impact of Molecular Profiling on Therapy Management in Breast Cancer
Flavia Ultimescu, Ariana Hudiță, Daniela Elena Popa, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 4995-4995
Open Access | Times Cited: 2
Occurrence, analysis and removal of pesticides, hormones, pharmaceuticals, and other contaminants in soil and water streams for the past two decades: a review
Sofian M. Kanan, Matthew A. Moyet, Khaled Obeideen, et al.
Research on Chemical Intermediates (2022) Vol. 48, Iss. 9, pp. 3633-3683
Closed Access | Times Cited: 12
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Obesity as a Risk Factor for Breast Cancer—The Role of miRNA
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15683-15683
Open Access | Times Cited: 10
EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN
O. Pridko, Т. Borikun, O. Rossylna, et al.
Experimental Oncology (2023) Vol. 44, Iss. 4, pp. 295-299
Open Access | Times Cited: 5
Circulating miR-221/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case–control study
Ilhamjaya Patellongi, Alfiah Amiruddin, Muhammad Nasrum Massi, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 8, pp. 3806-3815
Open Access | Times Cited: 4
Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway
Do Thi Minh Xuan, Chung-Che Wu, Wei‐Jan Wang, et al.
International Journal of Medical Sciences (2022) Vol. 20, Iss. 1, pp. 35-49
Open Access | Times Cited: 7
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
Freda Halim, Yohana Azhar, Suwarman Suwarman, et al.
F1000Research (2022) Vol. 11, pp. 330-330
Open Access | Times Cited: 5
Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen
Wilfan Ibadurrahman, Naufa Hanif, Adam Hermawan
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 66-66
Open Access | Times Cited: 5
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
Freda Halim, Yohana Azhar, Suwarman Suwarman, et al.
F1000Research (2022) Vol. 11, pp. 330-330
Open Access | Times Cited: 4
Targeting Drug Resistance in Breast Cancer: The Potential of miRNA and Nanotechnology-Driven Delivery Systems
Aditi Verma, Krunal Patel, Ashutosh Kumar
Nanoscale Advances (2024)
Open Access
High-throughput screen to uncover the role of microRNAs in Tamoxifen resistance and cell growth of ER-positive breast cancer
Zainab S. S. Al Hashami-Al Aamri
(2024)
Open Access
The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis
Y. Liu, Jingwen Li, Junying Li, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 8, pp. 883-895
Closed Access
PROSPECTS OF USING microRNAs AS PREDICTIVE MARKERS OF HORMONE-DEPENDENT BREAST CANCER
O. Pridko, Andriy Rusyn
Oncology (2023) Vol. 25, Iss. 4, pp. 255-261
Closed Access
Page 1

Scroll to top